Saphris

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA022117 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Saphris Is Indicated For: Schizophrenia In Adults [See Clinical Studies ( 14.1 )] Bipolar I Disorder [See Clinical Studies ( 14.2 )] Acute Monotherapy Of Manic Or Mixed Episodes, In Adults And Pediatric Patients 10 To 17 Years Of Age Adjunctive Treatment To Lithium Or Valproate In Adults Maintenance Monotherapy Treatment In Adults Saphris Is An Atypical Antipsychotic Indicated For ( 1 ): Schizophrenia In Adults Bipolar I Disorder Acute Monotherapy Treatment Of Manic Or Mixed Episodes, In Adults And Pediatric Patients 10 To 17 Years Of Age Adjunctive Treatment To Lithium Or Valproate In Adults Maintenance Monotherapy Treatment In Adults

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Asenapine Maleate ASENAPINE MALEATE ZINC12358683

Comments